# Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

**Recall Severity Score:** 55/100

| Field | Value |
|---|---|
| Firm | Plantimex |
| Product | Mamisan Pain Relieving Topical Ointment |
| Recall number | 26157 |
| Recall date | 2025-12-18 |
| Units | About 50,330 |
| Hazard | The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children. |
| Injuries reported | None reported |
| Remedy | Repair |
| Manufactured in | United States |
| Sold at | Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10. |
| Description | This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall. |

## Why this score
- Recognized injury hazard.
- About 50,330 units.
- Children's product.

Source: U.S. Consumer Product Safety Commission (CPSC) Recalls API (https://www.cpsc.gov/Recalls/2026/Plantimex-Recalls-Mamisan-Lidocaine-Ointment-Containers-Due-to-Risk-of-Serious-Injury-or-Death-from-Child-Poisoning-Violates-Mandatory-Standard-for-Child-Resistant-Packaging). Last refreshed: 2026-11-04T18:12:00.306Z.
Recall data comes from the CPSC and is summarized automatically; read the official notice before acting. Informational only; not legal advice.